Hemophilia A

All Gene Discoveries Are Not Equal by Lisa E. L. Patient Expert

When newspapers announce that a gene has been discovered for a certain disease — such as the recent findings of genes involved in chronic fatigue syndrome, schizophrenia, and obesity — we inevitably get calls from people interested in testing for that genetic finding. But “finding a gene” can mean a few different things. ... Read on »

Coagulation quiz by pathologystudent ... in vivo D. It is a commonly ordered test E. It evaluates the coagulation system 9. What is the most common inherited bleeding disorder?A. von Willebrand’s disease B. Hemophilia A C. Hemophilia B D. Factor V Leiden E. TTP 10. Which disorders may show “factor-type” bleeding?A. von Willebrand’s disease B. Hemophilia A C ... Read on »

Blood Clotting Drug Lysteda approved by FDA for Treatment of Heavy Bleeding with Menstrual Periods by Medical Quack Patient Expert

The state 3 trials were just completed. The article said use with contraception pills is also not a good idea. I believe this is one of the first non hormone treatment in a pill format (beyond what Midol can do) that had been approved to treat menstrual period with heavy bleeding. This is the same company that markets Darvon, located in Kentu ... Read on »

FDA Approves Lysteda to Treat Heavy Menstrual Bleeding by Health: Hearsay & Headlines The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot. Heavy menstrual bleeding is reported each year by about 3 million U.S. women of reproductive age. Women with ... Read on »

Promising Results Reported in First U.S. Clinical Trial Investigating the Use of Adult Stem Cells... by franklinb ((( article link ))) DALLAS, Nov. 16 /PRNewswire/ -- Researchers from three major academic medical centers reported promising results gleaned from the initial phase of the first U.S. clinical trial investigating the benefit of using a patient's own (autologous) selected adult stem cells, called CD34+ cells, to treat coronary artery disease. Dougla ... Read on »

Assisted reproductive technologies (ART) #5 PGD by SouadDreyfus Patient Expert

... ue to genetic disorders, who already have one child with a genetic problem, or who are carriers of a genetic disease. The procedure may detect Down syndrome, cystic fibrosis, hemophilia A, Tay-Sachs disease, and Turner syndrome, along with other disorders. PGD is performed in the laboratory by removing a single cell from each embryo. This cell is ... Read on »

Baxter Loses Medicare Reimbursement Suit by HealthCare This article in Forbes discusses how a US District Court has ruled against Baxter International Inc. stating that it is not entitled to a higher Medicare reimbursement price for its hemophilia drug Advate. Baxter has previously asked Medicare to reclassify the drug so that reimbursements would increase because according to Baxter its Medicare reimb ... Read on »

Tamiflu turned my children into hallucinating, sobbing wrecks & Baxter news by Andrew D. Read the full story hereSome information about Baxter, the producer of ‘Tamiflu’. “1980s and early 1990sAIDS - Anatomy of a Tragedy In the 1980’s the FDA banned Baxter from using certain blood products known to contain HIV and AIDS. So what did they do? They sold them to foreign countries with no warning about what they co ... Read on »

Swine flu - not lethal enough, vaccinate then decimate by Dr. Liz Miller Medical Doctor

It may sound mad, but this hypothesis is about to be tested on a massive scale. The government predicts The government predicts that there will be a second wave of swine flu, more lethal than the first. Swine flu needs a boost. 44 deaths in over 100,000 infections and cases falling off rapidly is reassuring nothing terrible is about to happen. ... Read on »

Hemophilia A - Articles

Wellsphere Info